Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Department of Justice
Dow
Federal Trade Commission
Cantor Fitzgerald
McKesson
McKinsey
Cerilliant
Baxter

Generated: June 21, 2018

DrugPatentWatch Database Preview

MIRALAX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Miralax patents expire, and when can generic versions of Miralax launch?

Miralax is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in MIRALAX is polyethylene glycol 3350. There are four hundred and nineteen drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
Drug patent expirations by year for MIRALAX
Synonyms for MIRALAX
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diol
6809-70-7
AC1L30Y6
AC1Q592L
AJ-84229
AK142231
AKOS022174815
AN-1760
BP-22861
CHEBI:46801
CTK2F8346
DTXSID70218291
EINECS 229-884-8
Ethylene oxide polymer
HO-PEG11-OH
J-525149
LP015637
MFCD26793839
PEG12
Polyethylene oxide
PSVXZQVXSXSQRO-UHFFFAOYSA-N
RL04599
SCHEMBL3486923
Undecaethylene glycol
Y4969
ZINC31308571

US Patents and Regulatory Information for MIRALAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc MIRALAX polyethylene glycol 3350 FOR SOLUTION;ORAL 022015-001 Oct 6, 2006 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
McKinsey
Mallinckrodt
Dow
Baxter
McKesson
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.